Guidance for market authorization requirements for COVID-19 vaccines: Overview

This document provides guidance on developing the evidence and documentation needed to obtain an authorization and licensing for importing or selling a COVID-19 vaccine in Canada.

Data and Resources

Additional Info

Field Value
Source
Version None
Author None
Author Email None
Maintainer None
Maintainer Email None
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French) Lignes directrices sur les exigences relatives aux autorisations de mise en marché des vaccins contre la COVID-19 : Aperçu
Update Frequency as_needed
Geographic Scope []
Criticality Level []
Sensitivity Level unrestricted
Language
Contact Person
Contact Email
Data Dictionary
Open Canada Date Published 2021-04-06 00:00:00
Open Canada Date Modified
Open Canada Subject ["health_and_safety"]
Open Canada Keywords {"fr": ["coronavirus", "COVID-19", "pandémie", "médicaments", "médicaments", "vaccins", "autorisation de mise sur le marché", "licence", "importation ou vente", "vaccin COVID-19"], "en": ["coronavirus", "COVID-19", "pandemic", "drugs", "medications", "vaccines", "market authorization", "licensing", "importing or selling", "COVID-19 vaccine"]}
Open Canada Collection publication
Principal Organization
Reference Data
Official Source